NRIX logo

Nurix Therapeutics (NRIX) CAPEX

annual CAPEX:

$9.27M+$872.00K(+10.38%)
November 30, 2024

Summary

  • As of today (June 27, 2025), NRIX annual capital expenditures is $9.27 million, with the most recent change of +$872.00 thousand (+10.38%) on November 30, 2024.
  • During the last 3 years, NRIX annual CAPEX has risen by +$3.61 million (+63.80%).
  • NRIX annual CAPEX is now -24.26% below its all-time high of $12.24 million, reached on November 30, 2022.

Performance

1-year change

+10.38%

3-year change

+63.8%

5-year change

+461.66%

15-year change

+481.38%

NRIX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

65.62%
NRIX annual capital expenditures is higher than 65.62% of companies in Healthcare sector

Range

All-time high

$12.24M
NRIX annual capital expenditures is currently -24.26% below its historical high of $12.24 million

3-year low

$5.66M
NRIX annual capital expenditures is currently +63.80% above its 3-year low

Earnings dates

Last annual earnings report date

Nov 30, 2024
NRIX previous annual earnings announcement was published on Nov 30, 2024

Next annual earnings report date

N/A
NRIX next annual earnings announcement has not yet been scheduled

OtherNRIXcash flow metrics

annual FCF

-$181.86M
NRIX annual free cash flow is -$181.86 million

annual CFO

-$172.58M
NRIX annual cash flow from operations is -$172.58 million

annual CFI

-$257.71M
NRIX annual cash flow from investing activities is -$257.71 million

annual CFF

$485.67M
NRIX annual cash flow from financing activities is $485.67 million

quarterly CAPEX:

$3.48M+$1.38M(+65.56%)
February 28, 2025

Summary

  • As of today (June 27, 2025), NRIX quarterly capital expenditures is $3.48 million, with the most recent change of +$1.38 million (+65.56%) on February 28, 2025.
  • Over the past year, NRIX quarterly CAPEX has increased by +$601.00 thousand (+20.84%).
  • NRIX quarterly CAPEX is now at all-time high.

Performance

3-month change

+65.56%

1-year change

+20.84%

3-year change

+0.37%

5-year change

+857.42%

NRIX quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

65.07%
NRIX quarterly capital expenditures is higher than 65.07% of companies in Healthcare sector

Range

All-time high

$3.48M
NRIX quarterly capital expenditures is currently at an all-time high

3-year low

$1.08M
NRIX quarterly capital expenditures is currently +222.69% above its 3-year low

Earnings dates

Last quarterly earnings report date

Feb 28, 2025
NRIX previous earnings announcement was published on Feb 28, 2025

Next quarterly earnings report date

Jul 11, 2025
NRIX next earnings announcement is scheduled for Jul 11, 2025

OtherNRIXcash flow metrics

quarterly FCF

-$64.57M
NRIX quarterly free cash flow is -$64.57 million

quarterly CFO

-$61.09M
NRIX quarterly cash flow from operations is -$61.09 million

quarterly CFI

$25.53M
NRIX quarterly cash flow from investing activities is $25.53 million

quarterly CFF

$1.47M
NRIX quarterly cash flow from financing activities is $1.47 million

TTM CAPEX:

$9.87M+$601.00K(+6.48%)
February 28, 2025

Summary

  • As of today (June 27, 2025), NRIX TTM capital expenditures is $9.87 million, with the most recent change of +$601.00 thousand (+6.48%) on February 28, 2025.
  • Over the past year, NRIX TTM CAPEX has increased by +$866.00 thousand (+9.61%).
  • NRIX TTM CAPEX is now -19.36% below its all-time high of $12.24 million, reached on November 30, 2022.

Performance

3-month change

+6.48%

1-year change

+9.61%

3-year change

+19.11%

5-year change

+399.44%

NRIX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

59.66%
NRIX TTM capital expenditures is higher than 59.66% of companies in Healthcare sector

Range

All-time high

$12.24M
NRIX TTM capital expenditures is currently -19.36% below its historical high of $12.24 million

3-year low

$8.38M
NRIX TTM capital expenditures is currently +17.81% above its 3-year low

Earnings dates

Last quarterly earnings report date

Feb 28, 2025
NRIX previous earnings announcement was published on Feb 28, 2025

Next quarterly earnings report date

Jul 11, 2025
NRIX next earnings announcement is scheduled for Jul 11, 2025

OtherNRIXcash flow metrics

TTM FCF

-$201.59M
NRIX TTM free cash flow is -$201.59 million

TTM CFO

-$191.72M
NRIX TTM cash flow from operations is -$191.72 million

TTM CFI

-$267.69M
NRIX TTM cash flow from investing activities is -$267.69 million

TTM CFF

$485.52M
NRIX TTM cash flow from financing activities is $485.52 million

NRIX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.4%+20.8%+9.6%
3 y3 years+63.8%+0.4%+19.1%
5 y5 years+461.7%+857.4%+399.4%

NRIX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.3%+63.8%at high+222.7%-19.4%+17.8%
5 y5-year-24.3%+461.7%at high+313.4%-19.4%+399.4%
alltimeall time-24.3%+481.4%at high+857.4%-19.4%+2612.6%

NRIX CAPEX History

DateAnnualQuarterlyTTM
Feb 2025
-
$3.48M(+65.6%)
$9.87M(+6.5%)
Nov 2024
$9.27M(+10.4%)
$2.10M(-10.3%)
$9.27M(-4.9%)
Aug 2024
-
$2.35M(+21.2%)
$9.75M(-1.1%)
May 2024
-
$1.94M(-32.8%)
$9.87M(+9.5%)
Feb 2024
-
$2.88M(+11.6%)
$9.01M(+7.2%)
Nov 2023
$8.40M(-31.4%)
$2.58M(+5.1%)
$8.40M(+0.2%)
Aug 2023
-
$2.46M(+127.7%)
$8.38M(-10.3%)
May 2023
-
$1.08M(-52.6%)
$9.34M(-15.5%)
Feb 2023
-
$2.28M(-11.2%)
$11.05M(-9.8%)
Nov 2022
$12.24M
$2.56M(-25.0%)
$12.24M(+16.2%)
Aug 2022
-
$3.42M(+22.6%)
$10.54M(+17.3%)
DateAnnualQuarterlyTTM
May 2022
-
$2.79M(-19.7%)
$8.99M(+8.4%)
Feb 2022
-
$3.47M(+302.8%)
$8.29M(+46.4%)
Nov 2021
$5.66M(+24.3%)
$862.00K(-53.8%)
$5.66M(-0.8%)
Aug 2021
-
$1.86M(-10.8%)
$5.71M(+3.5%)
May 2021
-
$2.09M(+148.0%)
$5.51M(+9.5%)
Feb 2021
-
$843.00K(-7.0%)
$5.03M(+10.5%)
Nov 2020
$4.55M(+175.8%)
$906.00K(-45.7%)
$4.55M(+24.8%)
Aug 2020
-
$1.67M(+3.5%)
$3.65M(+84.5%)
May 2020
-
$1.61M(+343.1%)
$1.98M(+443.1%)
Feb 2020
-
$364.00K
$364.00K
Nov 2019
$1.65M(+3.5%)
-
-
Nov 2018
$1.59M
-
-

FAQ

  • What is Nurix Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Nurix Therapeutics?
  • What is Nurix Therapeutics annual CAPEX year-on-year change?
  • What is Nurix Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Nurix Therapeutics?
  • What is Nurix Therapeutics quarterly CAPEX year-on-year change?
  • What is Nurix Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Nurix Therapeutics?
  • What is Nurix Therapeutics TTM CAPEX year-on-year change?

What is Nurix Therapeutics annual capital expenditures?

The current annual CAPEX of NRIX is $9.27M

What is the all time high annual CAPEX for Nurix Therapeutics?

Nurix Therapeutics all-time high annual capital expenditures is $12.24M

What is Nurix Therapeutics annual CAPEX year-on-year change?

Over the past year, NRIX annual capital expenditures has changed by +$872.00K (+10.38%)

What is Nurix Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of NRIX is $3.48M

What is the all time high quarterly CAPEX for Nurix Therapeutics?

Nurix Therapeutics all-time high quarterly capital expenditures is $3.48M

What is Nurix Therapeutics quarterly CAPEX year-on-year change?

Over the past year, NRIX quarterly capital expenditures has changed by +$601.00K (+20.84%)

What is Nurix Therapeutics TTM capital expenditures?

The current TTM CAPEX of NRIX is $9.87M

What is the all time high TTM CAPEX for Nurix Therapeutics?

Nurix Therapeutics all-time high TTM capital expenditures is $12.24M

What is Nurix Therapeutics TTM CAPEX year-on-year change?

Over the past year, NRIX TTM capital expenditures has changed by +$866.00K (+9.61%)
On this page